Patents by Inventor Liselotte Knudsen

Liselotte Knudsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GLP-2 Derivatives
    Publication number: 20080045450
    Abstract: Analogs of GLP-2, pharmaceutical compositions comprising GLP-2 analogs, and methods of treating diseases and disorders comprising administering such analogs or compositions are provided.
    Type: Application
    Filed: March 25, 2006
    Publication date: February 21, 2008
    Inventors: Liselotte Knudsen, Per Huusfeldt, Per Nielsen, Niels Kaarsholm, Helle Olsen, Lars Thim, Soren Bjorn
  • Combined Use of Derivatives of GLP-1 Analogs and PPAR Ligands
    Publication number: 20070287669
    Abstract: The present invention provides methods and compositions for treatment and/or prevention of type 1 and type 2 diabetes, dyslipdemia, impaired glucose tolerance, insulin resistance, obesity, and beta-cell apoptosis, as well as methods for increasing the size and number of beta-cells in a subject and/or stimulating beta-cell proliferation, which comprise administering both a stable GLP-1 analogue and a non-thiazolidinedione PPAR ligand.
    Type: Application
    Filed: August 23, 2007
    Publication date: December 13, 2007
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Knudsen, Karsten Wassermann, Jeppe Sturis, Christian Brand, Carsten Gotfredsen
  • Use of GLP-1 peptides
    Publication number: 20070161568
    Abstract: GLP-1(1-45) or a fragment or an analogue thereof can be used in the preparation of a medicament for peripheral administration in the suppression of appetite or induction of satiety.
    Type: Application
    Filed: March 5, 2007
    Publication date: July 12, 2007
    Applicant: Novo Nordisk A/S
    Inventors: Jens Holst, Arne Astrup, Martin Judge, Liselotte Knudsen, Lars Thim, Birgitte Wulff
  • Regulation of food preference using GLP-1 agonists
    Publication number: 20070082844
    Abstract: GLP-1 agonists selectively decrease the amount of food intake, wherein the food has a high glycemic index or wherein the amount of mono-and di-saccharides together constitute a large proportion of the total amount of carbohydrates.
    Type: Application
    Filed: June 7, 2006
    Publication date: April 12, 2007
    Applicant: Novo Nordisk A/S
    Inventors: Kirsten Raun, Pia Von Voss, Liselotte Knudsen, Kjell Malmlof
  • GLP-1 agonist and cardiovascular complations
    Publication number: 20070049531
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: October 25, 2006
    Publication date: March 1, 2007
    Inventors: Liselotte Knudsen, Bidda Rolin, Richard Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Nielsen, Christina Christoffersen
  • Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
    Publication number: 20060287221
    Abstract: Pharmaceutical composition for parenteral administration comprising a meal related insulin peptide and an insulinotropic peptide.
    Type: Application
    Filed: May 3, 2006
    Publication date: December 21, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Knudsen, Kristian Hansen, Dorthe Engelund, Svend Ludvigsen, Lars Hansen, Claude Bonde, Ejvind Jensen, Tine Elisabeth Boving, Morten Schlein
  • Derivatives of GLP-1 analogs
    Publication number: 20060199763
    Abstract: The present invention relates to a pharmaceutical composition comprising a GLP-1 derivative having a lipophilic substituent; and a surfactant.
    Type: Application
    Filed: December 9, 2004
    Publication date: September 7, 2006
    Inventors: Liselotte Knudsen, Per Huusfeldt, Per Nielsen, Niels Kaarsholm, Helle Olsen, Soren Bjorn, Freddy Pedersen, Kjeld Madsen
  • Combined use of derivatives of GLP-1 analogs and PPAR ligands
    Publication number: 20050239707
    Abstract: The present invention provides methods and compositions for treatment and/or prevention of type 1 and type 2 diabetes, dyslipdemia, impaired glucose tolerance, insulin resistance, obesity, and beta-cell apoptosis, as well as methods for increasing the size and number of beta-cells in a subject and/or stimulating beta-cell proliferation, which comprise administering both a stable GLP-1 analogue and a non-thiazolidinedione PPAR ligand.
    Type: Application
    Filed: June 7, 2005
    Publication date: October 27, 2005
    Inventors: Liselotte Knudsen, Karsten Wassermann, Jeppe Sturis, Christian Brand